Long-Term Human Albumin Fails to Improve Survival in Decompensated Cirrhosis

(MedPage Today) -- Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.
Treatment with human albumin...